Can a simple drug make liver transplants safer?
NCT ID NCT07157631
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a medicine called tranexamic acid can reduce blood loss during adult liver transplant surgery. About 1,546 people will be randomly assigned to receive either the drug or a placebo. The main goal is to see if the drug works better than placebo at controlling bleeding without increasing the risk of dangerous blood clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE LIVER DISEASE (ESLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anesthesiology, Renji Hospital, Shanghai Jiao Tong university school of medicine.
RECRUITINGShanghai, Shanghai Municipality, 200123, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple drug cut bleeding risk in weight-loss surgery?
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- Can a cell test free liver transplant patients from lifelong drugs?
- Smartphone messages may boost medication adherence after liver transplant
- Blood type no barrier? study tests liver transplant success across ABO barriers
- Less fluid, fewer complications? trial tests new strategy in liver transplants